Answers are grounded in this paper and cite their sources.
Subjects with affective or anxiety disorders who enter clinical trials have significant quality-of-life impairment, although the degree of dysfunction varies. Diagnostic-specific symptom measures explained only a small proportion of the variance in quality of life, suggesting that an individual's perception of quality of life is an additional factor that should be part of a complete assessment.
No takes yet. Share an insight, caveat, or question.
Rapaport et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: